KUALA LUMPUR, Dec 15 (Bernama) — Malaysia is projected to gain RM 2.1 billion in Gross National Income (GNI) through 3500 sponsored clinical research that are to be conducted between years 2023-2033, according to Clinical Research Malaysia. These targets were unveiled under CRM’s 10-year plan, which were recently presented in the Clinical Research Governance World Conference at Hong Kong, attended by leading clinical research networks.
Clinical Research Malaysia (CRM), a Global Trusted Research Management Organisation (GTRMO) by the Ministry of Health was established since 2012 to accelerate the sponsored clinical research ecosystem within the country. Within the first decade of its establishment (2012 -2022), clinical research in the country has generated a revenue of over RM 1 billion in GNI from over 2000 clinical research recorded.
